Preventive and therapeutic AIDS vaccines
OwnerQun Cheninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to prophylactic and therapeutic acquired immunodeficiency syndrome vaccines. In particular, the present invention provides methods and compositions utilizing recombinant HIV-1, HIV-2 and/or SIV genes or gene products in safe vaccination approaches.
Claims30
A method for administering a vaccine to a subject, comprising the steps of:
- a. providing a subject, and at least three subunit vaccines, wherein said vaccines together but not individually comprise a complete immunodeficiency virus genome encoding viral Gag, Pol, Env, regulatory and accessory proteins, in the absence of immunodeficiency virus long terminal repeats;
- and
- b. administering said vaccines to said subject under conditions suitable for inducing an immune response against said viral Gag, Pol, Env, regulatory and accessory proteins.
A method for producing a set of at least three subunit vaccines comprising the steps of:
- a. cloning genes of at least one immunodeficiency virus;
- b. mutating at least one of said genes;
- c. constructing a library by ligating said genes individually or in combination into at least one vector;
- and
- d. classifying members of said library into a set of at least three subunit vaccines, wherein said vaccines together but not individually comprise a complete immunodeficiency virus genome encoding viral Gag, Pol, Env, regulatory and accessory proteins, in the absence of immunodeficiency virus long terminal repeats.
A composition comprising at least three subunit vaccines, wherein said subunit vaccines together but not individually comprise a complete immunodeficiency virus genome encoding viral Gag, Pol, Env, regulator and accessory proteins, in the absence of immunodeficiency virus long terminal repeats.
Dependencies are inferred from the claim text.